Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association

American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.

Original languageEnglish (US)
Pages (from-to)e30-e66
JournalCirculation
Volume137
Issue number8
DOIs
StatePublished - Feb 20 2018

Fingerprint

Cardiovascular Diseases
Breast Neoplasms
Therapeutics
Preexisting Condition Coverage
Heart Neoplasms
Mortality
Left Ventricular Dysfunction
Women's Health
Survivors
Obesity
Smoking
Health
Neoplasms

Keywords

  • AHA Scientific Statement
  • breast cancer
  • cardiotoxicity
  • cardiovascular disease
  • oncology
  • prevention
  • risk factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research (2018). Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation, 137(8), e30-e66. https://doi.org/10.1161/CIR.0000000000000556

Cardiovascular Disease and Breast Cancer : Where These Entities Intersect: A Scientific Statement From the American Heart Association. / American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research.

In: Circulation, Vol. 137, No. 8, 20.02.2018, p. e30-e66.

Research output: Contribution to journalArticle

American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research 2018, 'Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association', Circulation, vol. 137, no. 8, pp. e30-e66. https://doi.org/10.1161/CIR.0000000000000556
American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research. Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association. Circulation. 2018 Feb 20;137(8):e30-e66. https://doi.org/10.1161/CIR.0000000000000556
American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research. / Cardiovascular Disease and Breast Cancer : Where These Entities Intersect: A Scientific Statement From the American Heart Association. In: Circulation. 2018 ; Vol. 137, No. 8. pp. e30-e66.
@article{c00f0213f14b455197daa9575e10c905,
title = "Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association",
abstract = "Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.",
keywords = "AHA Scientific Statement, breast cancer, cardiotoxicity, cardiovascular disease, oncology, prevention, risk factors",
author = "{American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research} and Mehta, {Laxmi S.} and Watson, {Karol E.} and Ana Barac and Beckie, {Theresa M.} and Vera Bittner and Salvador Cruz-Flores and Susan Dent and Lavanya Kondapalli and Bonnie Ky and Tochukwu Okwuosa and Pina, {Ileana L.} and Volgman, {Annabelle Santos}",
year = "2018",
month = "2",
day = "20",
doi = "10.1161/CIR.0000000000000556",
language = "English (US)",
volume = "137",
pages = "e30--e66",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Cardiovascular Disease and Breast Cancer

T2 - Where These Entities Intersect: A Scientific Statement From the American Heart Association

AU - American Heart Association Cardiovascular Disease in Women and Special Populations Committee of the Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; and Council on Quality of Care and Outcomes Research

AU - Mehta, Laxmi S.

AU - Watson, Karol E.

AU - Barac, Ana

AU - Beckie, Theresa M.

AU - Bittner, Vera

AU - Cruz-Flores, Salvador

AU - Dent, Susan

AU - Kondapalli, Lavanya

AU - Ky, Bonnie

AU - Okwuosa, Tochukwu

AU - Pina, Ileana L.

AU - Volgman, Annabelle Santos

PY - 2018/2/20

Y1 - 2018/2/20

N2 - Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.

AB - Cardiovascular disease (CVD) remains the leading cause of mortality in women, yet many people perceive breast cancer to be the number one threat to women's health. CVD and breast cancer have several overlapping risk factors, such as obesity and smoking. Additionally, current breast cancer treatments can have a negative impact on cardiovascular health (eg, left ventricular dysfunction, accelerated CVD), and for women with pre-existing CVD, this might influence cancer treatment decisions by both the patient and the provider. Improvements in early detection and treatment of breast cancer have led to an increasing number of breast cancer survivors who are at risk of long-term cardiac complications from cancer treatments. For older women, CVD poses a greater mortality threat than breast cancer itself. This is the first scientific statement from the American Heart Association on CVD and breast cancer. This document will provide a comprehensive overview of the prevalence of these diseases, shared risk factors, the cardiotoxic effects of therapy, and the prevention and treatment of CVD in breast cancer patients.

KW - AHA Scientific Statement

KW - breast cancer

KW - cardiotoxicity

KW - cardiovascular disease

KW - oncology

KW - prevention

KW - risk factors

UR - http://www.scopus.com/inward/record.url?scp=85063972825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063972825&partnerID=8YFLogxK

U2 - 10.1161/CIR.0000000000000556

DO - 10.1161/CIR.0000000000000556

M3 - Article

C2 - 29437116

AN - SCOPUS:85063972825

VL - 137

SP - e30-e66

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 8

ER -